Related Experiment Video
Updated: Aug 9, 2025
08:52
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
4.1K
Moving toward precision medicine with lung cancer organoids
1Department of Internal Medicine, Division of Hematology-Oncology, University of Texas Southwestern, Dallas, TX 75208, USA; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern, Dallas, TX 75208, USA; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX 75208, USA.
Cell Reports. Medicine
|February 22, 2023
Abstract:
In this issue of Cell Reports Medicine, Wang et al.1 generated 160 human lung cancer organoids, primarily from malignant effusions, and tested their responses to clinically used drugs to determine whether the ex vivo organoid responses predicted patient responses.
